Search results

Defence requirements push your technology, we can help. ANSTO is home to some of Australia’s most important landmark research infrastructure – more than $1.3bn of it.  Our unique capabilities are used by thousands of Australian researchers from industry and academia every year.

Meeting of minds about potential next-generation cancer treatment for Australians

International study has revealed a clustering of charged particles in the microgravity environment of space,with implications for the development of materials and better drugs that depend on the mixing of two or more charged particles.

Radioactive phosphorous for implantable medical device to treat pancreatic cancer in global clinical trial

Combined imaging approach characterises plaques associated with disease.

Million year lag time in transport of sediment in Murray Darling River Basin system.

Neutron scattering has contributed to a 'tour de force' of chemistry led by Monash University.

Shorebirds Competition 2022 results.

Australia’s nuclear agency ANSTO is continuing to lead planning efforts to repatriate what is called a TN-81 cask of intermediate-level radioactive from the United Kingdom in 2022.

Melbourne researchers have used the Australian Synchrotron to produce structure of molecule known to play a critical role in the development and spread of aggressive cancer.

Experiments at the Synchrotron enable researchers to produce a 3D structure of a molecular scaffold with role in cancer

This COVIDSafe Plan describes the actions that ANSTO will take to keep our staff, contractors and visitors and platform users and collaborators safe and minimise the risk of the spread of COVID-19 infection.